hRPC Cell Therapy Demonstrates Sustained and Further Improvement in Vision at 60 and 120 Days in First Cohort of Phase 2a study in Retinitis Pigmentosa
Mean Change from Baseline in Visual Acuity of +23 Letters to Date
PR Newswire
LONDON, April 26, 2019